Description of Event or Problem · 0
BASED ON THE INFORMATION/REPORT PROVIDED BY THE SALES REPRESENTATIVE, KELLIE TEEL, RN, INJECTED THE 33-YEAR-OLD FEMALE PATIENT ON (B)(6) 2023 WITH LOT 22K141 OF REVANESSE LIPS+ 1.2 ML - (B)(6). THE FOLLOWING WAS THE CONCERN: "DID THIS GIRLS LIPS LAST NIGHT AND SHE IS CONCERNED THAT FILLER IS OUTSIDE OF THE LIPS. I TOLD HER IT SHOULD NOT BE OUTSIDE OF THE LIPS. LIKELY STILL SWOLLEN. SHE DOES HAVE A NEW CREASE ON THE RIGHT SIDE IF LOOKING AT THE PICTURE." PROLLENIUM MEDICAL TECHNOLOGIES INC. HAS CONTACTED THE CLINIC FOUR TIMES VIA EMAIL AND PHONE (20-MAR-2023, 23-MAR-2023, 03-APR-2023, 18-APR-2023) TO OBTAIN ADDITIONAL INFORMATION ASSOCIATED WITH THE REPORTED ADVERSE EVENT. THE CLINIC DID NOT RESPOND. QA DEPARTMENT AT PROLLENIUM MEDICAL TECHNOLOGIES WILL CONTINUE THE INVESTIGATION. 3004423487-2023-00007, SWELLING (E2338), NOT RELATED TO THE DEVICE (A24) INTERNAL REPORT NUMBER: (B)(4).